Copyright Reports & Markets. All rights reserved.

Global Plasma-derived Product Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Plasma-derived Product Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Coagulation Factor
    • 1.2.3 Immune Globulin
    • 1.2.4 Albumin
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Plasma-derived Product Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Plasma-derived Product Market Perspective (2016-2027)
  • 2.2 Plasma-derived Product Growth Trends by Regions
    • 2.2.1 Plasma-derived Product Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Plasma-derived Product Historic Market Share by Regions (2016-2021)
    • 2.2.3 Plasma-derived Product Forecasted Market Size by Regions (2022-2027)
  • 2.3 Plasma-derived Product Industry Dynamic
    • 2.3.1 Plasma-derived Product Market Trends
    • 2.3.2 Plasma-derived Product Market Drivers
    • 2.3.3 Plasma-derived Product Market Challenges
    • 2.3.4 Plasma-derived Product Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Plasma-derived Product Players by Revenue
    • 3.1.1 Global Top Plasma-derived Product Players by Revenue (2016-2021)
    • 3.1.2 Global Plasma-derived Product Revenue Market Share by Players (2016-2021)
  • 3.2 Global Plasma-derived Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Plasma-derived Product Revenue
  • 3.4 Global Plasma-derived Product Market Concentration Ratio
    • 3.4.1 Global Plasma-derived Product Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Plasma-derived Product Revenue in 2020
  • 3.5 Plasma-derived Product Key Players Head office and Area Served
  • 3.6 Key Players Plasma-derived Product Product Solution and Service
  • 3.7 Date of Enter into Plasma-derived Product Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Plasma-derived Product Breakdown Data by Type

  • 4.1 Global Plasma-derived Product Historic Market Size by Type (2016-2021)
  • 4.2 Global Plasma-derived Product Forecasted Market Size by Type (2022-2027)

5 Plasma-derived Product Breakdown Data by Application

  • 5.1 Global Plasma-derived Product Historic Market Size by Application (2016-2021)
  • 5.2 Global Plasma-derived Product Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Plasma-derived Product Market Size (2016-2027)
  • 6.2 North America Plasma-derived Product Market Size by Type
    • 6.2.1 North America Plasma-derived Product Market Size by Type (2016-2021)
    • 6.2.2 North America Plasma-derived Product Market Size by Type (2022-2027)
    • 6.2.3 North America Plasma-derived Product Market Size by Type (2016-2027)
  • 6.3 North America Plasma-derived Product Market Size by Application
    • 6.3.1 North America Plasma-derived Product Market Size by Application (2016-2021)
    • 6.3.2 North America Plasma-derived Product Market Size by Application (2022-2027)
    • 6.3.3 North America Plasma-derived Product Market Size by Application (2016-2027)
  • 6.4 North America Plasma-derived Product Market Size by Country
    • 6.4.1 North America Plasma-derived Product Market Size by Country (2016-2021)
    • 6.4.2 North America Plasma-derived Product Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Plasma-derived Product Market Size (2016-2027)
  • 7.2 Europe Plasma-derived Product Market Size by Type
    • 7.2.1 Europe Plasma-derived Product Market Size by Type (2016-2021)
    • 7.2.2 Europe Plasma-derived Product Market Size by Type (2022-2027)
    • 7.2.3 Europe Plasma-derived Product Market Size by Type (2016-2027)
  • 7.3 Europe Plasma-derived Product Market Size by Application
    • 7.3.1 Europe Plasma-derived Product Market Size by Application (2016-2021)
    • 7.3.2 Europe Plasma-derived Product Market Size by Application (2022-2027)
    • 7.3.3 Europe Plasma-derived Product Market Size by Application (2016-2027)
  • 7.4 Europe Plasma-derived Product Market Size by Country
    • 7.4.1 Europe Plasma-derived Product Market Size by Country (2016-2021)
    • 7.4.2 Europe Plasma-derived Product Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Plasma-derived Product Market Size (2016-2027)
  • 8.2 Asia-Pacific Plasma-derived Product Market Size by Type
    • 8.2.1 Asia-Pacific Plasma-derived Product Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Plasma-derived Product Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Plasma-derived Product Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Plasma-derived Product Market Size by Application
    • 8.3.1 Asia-Pacific Plasma-derived Product Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Plasma-derived Product Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Plasma-derived Product Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Plasma-derived Product Market Size by Region
    • 8.4.1 Asia-Pacific Plasma-derived Product Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Plasma-derived Product Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Plasma-derived Product Market Size (2016-2027)
  • 9.2 Latin America Plasma-derived Product Market Size by Type
    • 9.2.1 Latin America Plasma-derived Product Market Size by Type (2016-2021)
    • 9.2.2 Latin America Plasma-derived Product Market Size by Type (2022-2027)
    • 9.2.3 Latin America Plasma-derived Product Market Size by Type (2016-2027)
  • 9.3 Latin America Plasma-derived Product Market Size by Application
    • 9.3.1 Latin America Plasma-derived Product Market Size by Application (2016-2021)
    • 9.3.2 Latin America Plasma-derived Product Market Size by Application (2022-2027)
    • 9.3.3 Latin America Plasma-derived Product Market Size by Application (2016-2027)
  • 9.4 Latin America Plasma-derived Product Market Size by Country
    • 9.4.1 Latin America Plasma-derived Product Market Size by Country (2016-2021)
    • 9.4.2 Latin America Plasma-derived Product Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Plasma-derived Product Market Size (2016-2027)
  • 10.2 Middle East & Africa Plasma-derived Product Market Size by Type
    • 10.2.1 Middle East & Africa Plasma-derived Product Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Plasma-derived Product Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Plasma-derived Product Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Plasma-derived Product Market Size by Application
    • 10.3.1 Middle East & Africa Plasma-derived Product Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Plasma-derived Product Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Plasma-derived Product Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Plasma-derived Product Market Size by Country
    • 10.4.1 Middle East & Africa Plasma-derived Product Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Plasma-derived Product Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Takeda
    • 11.1.1 Takeda Company Details
    • 11.1.2 Takeda Business Overview
    • 11.1.3 Takeda Plasma-derived Product Introduction
    • 11.1.4 Takeda Revenue in Plasma-derived Product Business (2016-2021)
    • 11.1.5 Takeda Recent Development
  • 11.2 CSL
    • 11.2.1 CSL Company Details
    • 11.2.2 CSL Business Overview
    • 11.2.3 CSL Plasma-derived Product Introduction
    • 11.2.4 CSL Revenue in Plasma-derived Product Business (2016-2021)
    • 11.2.5 CSL Recent Development
  • 11.3 Grifols
    • 11.3.1 Grifols Company Details
    • 11.3.2 Grifols Business Overview
    • 11.3.3 Grifols Plasma-derived Product Introduction
    • 11.3.4 Grifols Revenue in Plasma-derived Product Business (2016-2021)
    • 11.3.5 Grifols Recent Development
  • 11.4 Octapharma
    • 11.4.1 Octapharma Company Details
    • 11.4.2 Octapharma Business Overview
    • 11.4.3 Octapharma Plasma-derived Product Introduction
    • 11.4.4 Octapharma Revenue in Plasma-derived Product Business (2016-2021)
    • 11.4.5 Octapharma Recent Development
  • 11.5 Kedrion
    • 11.5.1 Kedrion Company Details
    • 11.5.2 Kedrion Business Overview
    • 11.5.3 Kedrion Plasma-derived Product Introduction
    • 11.5.4 Kedrion Revenue in Plasma-derived Product Business (2016-2021)
    • 11.5.5 Kedrion Recent Development
  • 11.6 LFB Group
    • 11.6.1 LFB Group Company Details
    • 11.6.2 LFB Group Business Overview
    • 11.6.3 LFB Group Plasma-derived Product Introduction
    • 11.6.4 LFB Group Revenue in Plasma-derived Product Business (2016-2021)
    • 11.6.5 LFB Group Recent Development
  • 11.7 Biotest
    • 11.7.1 Biotest Company Details
    • 11.7.2 Biotest Business Overview
    • 11.7.3 Biotest Plasma-derived Product Introduction
    • 11.7.4 Biotest Revenue in Plasma-derived Product Business (2016-2021)
    • 11.7.5 Biotest Recent Development
  • 11.8 BPL
    • 11.8.1 BPL Company Details
    • 11.8.2 BPL Business Overview
    • 11.8.3 BPL Plasma-derived Product Introduction
    • 11.8.4 BPL Revenue in Plasma-derived Product Business (2016-2021)
    • 11.8.5 BPL Recent Development
  • 11.9 RAAS
    • 11.9.1 RAAS Company Details
    • 11.9.2 RAAS Business Overview
    • 11.9.3 RAAS Plasma-derived Product Introduction
    • 11.9.4 RAAS Revenue in Plasma-derived Product Business (2016-2021)
    • 11.9.5 RAAS Recent Development
  • 11.10 CBPO
    • 11.10.1 CBPO Company Details
    • 11.10.2 CBPO Business Overview
    • 11.10.3 CBPO Plasma-derived Product Introduction
    • 11.10.4 CBPO Revenue in Plasma-derived Product Business (2016-2021)
    • 11.10.5 CBPO Recent Development
  • 11.11 Hualan Bio
    • 11.11.1 Hualan Bio Company Details
    • 11.11.2 Hualan Bio Business Overview
    • 11.11.3 Hualan Bio Plasma-derived Product Introduction
    • 11.11.4 Hualan Bio Revenue in Plasma-derived Product Business (2016-2021)
    • 11.11.5 Hualan Bio Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Plasma-derived Product Scope and Market Size
    Plasma-derived Product market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma-derived Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Coagulation Factor
    Immune Globulin
    Albumin
    Others

    Segment by Application
    Hospital
    Retail Pharmacy
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio

    Buy now